Blood compatibility of widely used central venous catheters; an experimental study

Hulda Thorarinsdottir1,2, Thomas Kander3,4, Dorota Johansson5,6

  • 1Department of Clinical Sciences, Lund University, Lund, Sweden.

Scientific Reports
|May 21, 2022
PubMed

Insights

Central venous catheters (CVCs) impact blood cells and immune responses. A polyurethane CVC with chlorhexidine and silver sulfadiazine showed the least favorable blood compatibility in this study.

Area of Science:

  • Biomaterials Science
  • Medical Device Engineering
  • Immunology

Background:

  • Central venous catheters (CVCs) are foreign materials that can trigger host defense mechanisms, leading to inflammation and thrombus formation.
  • Understanding the blood compatibility of CVCs is crucial for patient safety and effective clinical use.

Purpose of the Study:

  • To evaluate and compare the blood compatibility of six commonly used CVC materials.
  • To identify CVC materials with more favorable hemocompatic profiles.

Main Methods:

  • A modified Chandler loop model was used to test three coated and three uncoated CVC materials.
  • Blood from ten healthy volunteers circulated through each catheter material for one hour.
  • Blood cell counts and measurements of host defense systems (coagulation, complement, inflammatory markers) were analyzed.

Main Results:

  • All tested CVC materials affected blood cells, coagulation, complement system, or inflammatory markers to varying degrees.
  • A polyurethane CVC coated with chlorhexidine and silver sulfadiazine exhibited the most unfavorable blood compatibility.
  • A silicone dialysis catheter showed the greatest variability in blood compatibility across test runs.

Conclusions:

  • The blood compatibility of CVCs varies significantly among different materials and coatings.
  • The polyurethane CVC with chlorhexidine and silver sulfadiazine demonstrated poor blood compatibility.
  • Further clinical evaluation is needed to determine the clinical significance of these findings.